Trial Profile
Retrospective study of replacing zoledronic acid with denosumab patients with metastatic bone cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Bone cancer
- Focus Adverse reactions
- 07 Dec 2018 New trial record